Ling-Chun Chen

734 total citations
22 papers, 606 citations indexed

About

Ling-Chun Chen is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Ling-Chun Chen has authored 22 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomaterials, 6 papers in Molecular Biology and 6 papers in Pharmaceutical Science. Recurrent topics in Ling-Chun Chen's work include Nanoparticle-Based Drug Delivery (6 papers), Advancements in Transdermal Drug Delivery (5 papers) and Electrospun Nanofibers in Biomedical Applications (4 papers). Ling-Chun Chen is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Advancements in Transdermal Drug Delivery (5 papers) and Electrospun Nanofibers in Biomedical Applications (4 papers). Ling-Chun Chen collaborates with scholars based in Taiwan, United States and Vietnam. Ling-Chun Chen's co-authors include Ming‐Thau Sheu, Hsiu‐O Ho, Hong-Liang Lin, Der-Zen Liu, Chien‐Ming Hsieh, Shyr-Yi Lin, Ying‐Chen Chen, Yuan‐Soon Ho, Meng–Huang Wu and Michael Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Ling-Chun Chen

21 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling-Chun Chen Taiwan	14	189	170	165	98	74	22	606
Riham I. El-Gogary Egypt	12	251 1.3×	162 1.0×	221 1.3×	143 1.5×	47 0.6×	20	723
Young‐Guk Na South Korea	18	175 0.9×	348 2.0×	193 1.2×	119 1.2×	43 0.6×	47	795
Ali H. Alamri Saudi Arabia	16	197 1.0×	191 1.1×	149 0.9×	156 1.6×	52 0.7×	56	714
Farhat Fatima Saudi Arabia	18	180 1.0×	321 1.9×	140 0.8×	91 0.9×	47 0.6×	43	773
Khaled Shalaby Saudi Arabia	19	205 1.1×	463 2.7×	233 1.4×	97 1.0×	52 0.7×	40	1.0k
Linghui Dian China	8	171 0.9×	225 1.3×	205 1.2×	77 0.8×	36 0.5×	10	585
Solmaz Ghaffari Iran	15	118 0.6×	241 1.4×	151 0.9×	54 0.6×	43 0.6×	24	560
João Dias-Ferreira Portugal	14	173 0.9×	270 1.6×	161 1.0×	137 1.4×	29 0.4×	19	782
Mohammed Muqtader Ahmed Saudi Arabia	22	238 1.3×	436 2.6×	247 1.5×	136 1.4×	78 1.1×	81	1.1k
Sunitha Sampathi India	16	193 1.0×	315 1.9×	190 1.2×	109 1.1×	64 0.9×	37	734

Countries citing papers authored by Ling-Chun Chen

Since Specialization

Citations

This map shows the geographic impact of Ling-Chun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling-Chun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling-Chun Chen more than expected).

Fields of papers citing papers by Ling-Chun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling-Chun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling-Chun Chen. The network helps show where Ling-Chun Chen may publish in the future.

Co-authorship network of co-authors of Ling-Chun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ling-Chun Chen. A scholar is included among the top collaborators of Ling-Chun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling-Chun Chen. Ling-Chun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ho, Hsiu‐O, et al.. (2021). Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas. International Journal of Nanomedicine. Volume 16. 6825–6841. 9 indexed citations

Chen, Ling-Chun, et al.. (2021). CPT11 with P-glycoprotein/CYP 3A4 dual-function inhibitor by self-nanoemulsifying nanoemulsion combined with gastroretentive technology to enhance the oral bioavailability and therapeutic efficacy against pancreatic adenocarcinomas. Drug Delivery. 28(1). 2205–2217. 8 indexed citations

Lin, Hong-Liang, et al.. (2021). Honokiol/Magnolol-Loaded Self-Assembling Lecithin-Based Mixed Polymeric Micelles (lbMPMs) for Improving Solubility to Enhance Oral Bioavailability. International Journal of Nanomedicine. Volume 16. 651–665. 35 indexed citations

Lin, Shyr-Yi, Michael Chen, Ling-Chun Chen, et al.. (2021). Active Tumoral/Tumor Environmental Dual-Targeting by Non-Covalently Arming with Trispecific Antibodies or Dual-Bispecific Antibodies on Docetaxel-Loaded mPEGylated Nanocarriers to Enhance Chemotherapeutic Efficacy and Minimize Systemic Toxicity. International Journal of Nanomedicine. Volume 16. 4017–4030. 11 indexed citations

Chen, Ling-Chun, Shyr-Yi Lin, Ming‐Thau Sheu, et al.. (2021). Fabrication and characterization of Rhizochitosan and its incorporation with platelet concentrates to promote wound healing. Carbohydrate Polymers. 268. 118239–118239. 12 indexed citations

Wu, Meng–Huang, Weu Wang, Chien‐Ming Hsieh, et al.. (2020). One-pot fabrication of sacchachitin for production of TEMPO-oxidized sacchachitin nanofibers (TOSCNFs) utilized as scaffolds to enhance bone regeneration. Carbohydrate Polymers. 254. 117270–117270. 6 indexed citations

Wu, Meng–Huang, Ling-Chun Chen, Hong-Liang Lin, et al.. (2019). Preparation and characterization of chemically TEMPO-oxidized and mechanically disintegrated sacchachitin nanofibers (SCNF) for enhanced diabetic wound healing. Carbohydrate Polymers. 229. 115507–115507. 25 indexed citations

Chen, Ling-Chun, et al.. (2018). Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy. International Journal of Nanomedicine. Volume 13. 7079–7094. 43 indexed citations

Hsieh, Chien‐Ming, et al.. (2018). Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer. Drug Delivery. 25(1). 632–643. 27 indexed citations

10.

Chen, Michael, et al.. (2018). Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors. Drug Delivery. 25(1). 1066–1079. 22 indexed citations

11.

Liu, Jun‐Jen, Yuan‐Soon Ho, Yi-You Huang, et al.. (2017). Development and characterization of docetaxel-loaded lecithin-stabilized micellar drug delivery system (L sb MDDs) for improving the therapeutic efficacy and reducing systemic toxicity. European Journal of Pharmaceutics and Biopharmaceutics. 123. 9–19. 31 indexed citations

12.

Chen, Ling-Chun, et al.. (2017). Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs). Scientific Reports. 7(1). 10674–10674. 16 indexed citations

13.

Chen, Ling-Chun, et al.. (2016). Development and Characterization of Lecithin-based Self-assembling Mixed Polymeric Micellar (saMPMs) Drug Delivery Systems for Curcumin. Scientific Reports. 6(1). 37122–37122. 56 indexed citations

14.

Sheu, Ming‐Thau, et al.. (2016). Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study. International Journal of Nanomedicine. 11. 1557–1557. 44 indexed citations

15.

Sheu, Ming‐Thau, et al.. (2016). Codelivery of doxorubicin-containing thermosensitive hydrogels incorporated with docetaxel-loaded mixed micelles enhances local cancer therapy. Colloids and Surfaces B Biointerfaces. 143. 260–270. 57 indexed citations

16.

Chen, Ling-Chun, et al.. (2016). Improving the Stability of Astaxanthin by Microencapsulation in Calcium Alginate Beads. PLoS ONE. 11(4). e0153685–e0153685. 58 indexed citations

17.

Chen, Ling-Chun, Ying‐Chen Chen, Ming‐Thau Sheu, et al.. (2015). Mycelial Mattress from a Sporangia Formation-Delayed Mutant of Rhizopus stolonifer as Wound Healing-Enhancing Biomaterial. PLoS ONE. 10(8). e0134090–e0134090. 6 indexed citations

18.

Sheu, Ming‐Thau, et al.. (2003). Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. Journal of Controlled Release. 88(3). 355–368. 60 indexed citations

19.

Sheu, Ming‐Thau, et al.. (2002). Simultaneous optimization of percutaneous delivery and adhesion for ketoprofen poultice. International Journal of Pharmaceutics. 233(1-2). 257–262. 11 indexed citations

20.

Chen, Ling-Chun, et al.. (1998). Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. Journal of Controlled Release. 51(2-3). 301–311. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact